Viewing Study NCT05058560


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2025-12-26 @ 1:40 AM
Study NCT ID: NCT05058560
Status: COMPLETED
Last Update Posted: 2025-03-13
First Post: 2021-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab in Addition to BACE in Patients with NSCLC
Sponsor: The First Affiliated Hospital of Zhengzhou University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module